CY1105624T1 - Αντιγλαυκωματικο μεσο και χρηση αυτου - Google Patents
Αντιγλαυκωματικο μεσο και χρηση αυτουInfo
- Publication number
- CY1105624T1 CY1105624T1 CY20061100845T CY061100845T CY1105624T1 CY 1105624 T1 CY1105624 T1 CY 1105624T1 CY 20061100845 T CY20061100845 T CY 20061100845T CY 061100845 T CY061100845 T CY 061100845T CY 1105624 T1 CY1105624 T1 CY 1105624T1
- Authority
- CY
- Cyprus
- Prior art keywords
- antiglaucoma
- antiglacoma
- agent
- glaucoma
- administered
- Prior art date
Links
- 230000001384 anti-glaucoma Effects 0.000 abstract 3
- 208000010412 Glaucoma Diseases 0.000 abstract 1
- 102000004407 Lactalbumin Human genes 0.000 abstract 1
- 108090000942 Lactalbumin Proteins 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000008177 pharmaceutical agent Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/08—Mydriatics or cycloplegics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Ophthalmology & Optometry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Dental Preparations (AREA)
- Absorbent Articles And Supports Therefor (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Η παρούσα εφεύρεση αφορά φαρμακευτικά μέσα με βάση αντιγλαυκωματικές ουσίες καθώς και τη χρήση τους για τη θεραπεία γλαυκωμάτων. Τα μέσα αυτά περιέχουν υδρόλυμα λακταλβουμίνης ή ένα κλάσμα του. Έτσι, τα αντιγλαυκωματικά μπορούν να χορηγηθούν σε σημαντικά μικρότερες δόσεις σε σχέση με αυτές που συνήθως απαιτούνται για να επιτευχθεί συγκεκριμένη αντιγλαυκωματική δράση.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10158037A DE10158037A1 (de) | 2001-11-27 | 2001-11-27 | Antiglaukomatöses Mittel und dessen Verwendung |
| PCT/EP2002/013386 WO2003045417A1 (de) | 2001-11-27 | 2002-11-27 | Antiglaukomatoses mittel und dessen verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1105624T1 true CY1105624T1 (el) | 2010-12-22 |
Family
ID=7707053
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20061100845T CY1105624T1 (el) | 2001-11-27 | 2006-06-21 | Αντιγλαυκωματικο μεσο και χρηση αυτου |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20050043214A1 (el) |
| EP (1) | EP1448219B1 (el) |
| AT (1) | ATE320817T1 (el) |
| AU (1) | AU2002356739A1 (el) |
| CY (1) | CY1105624T1 (el) |
| DE (2) | DE10158037A1 (el) |
| DK (1) | DK1448219T3 (el) |
| ES (1) | ES2261786T3 (el) |
| PT (1) | PT1448219E (el) |
| WO (1) | WO2003045417A1 (el) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8299079B2 (en) * | 2009-05-22 | 2012-10-30 | Kaufman Herbert E | Preparations and methods for ameliorating or reducing presbyopia |
| US20180318319A1 (en) | 2017-05-04 | 2018-11-08 | Ocular Science, Inc. | Compositions and Methods for Treating Eyes and Methods of Preparation |
| US11071724B2 (en) | 2019-05-17 | 2021-07-27 | Ocular Science, Inc. | Compositions and methods for treating presbyopia |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4281654A (en) * | 1980-04-07 | 1981-08-04 | Alza Corporation | Drug delivery system for controlled ocular therapy |
| JPH0732718B2 (ja) * | 1985-01-18 | 1995-04-12 | クマ−ル ガウリ，カイラツシユ | 蛋白加水分解物およびその製造法 |
| DE3829552A1 (de) * | 1988-08-31 | 1990-03-01 | Gauri Kailash Kumar | Milchbestandteile, verfahren zu ihrer herstellung und mittel, die diese bestandteile enthalten |
| DE3922453A1 (de) * | 1989-07-07 | 1991-01-17 | Gauri Kailash Kumar | Pharmakologisch wirksame produkte aus molkeproteinhydrolysaten und verfahren zu deren gewinnung |
| US5182102A (en) * | 1991-07-12 | 1993-01-26 | Alcon Laboratories, Inc. | Anti-glaucoma compositions |
| US20040220089A1 (en) * | 2001-10-03 | 2004-11-04 | Ellis Edward J. | Ophthalmic preparation containing glycoprotein |
-
2001
- 2001-11-27 DE DE10158037A patent/DE10158037A1/de not_active Ceased
-
2002
- 2002-11-27 US US10/496,949 patent/US20050043214A1/en not_active Abandoned
- 2002-11-27 WO PCT/EP2002/013386 patent/WO2003045417A1/de not_active Application Discontinuation
- 2002-11-27 DK DK02803801T patent/DK1448219T3/da active
- 2002-11-27 AT AT02803801T patent/ATE320817T1/de active
- 2002-11-27 EP EP02803801A patent/EP1448219B1/de not_active Expired - Lifetime
- 2002-11-27 PT PT02803801T patent/PT1448219E/pt unknown
- 2002-11-27 AU AU2002356739A patent/AU2002356739A1/en not_active Abandoned
- 2002-11-27 ES ES02803801T patent/ES2261786T3/es not_active Expired - Lifetime
- 2002-11-27 DE DE50206173T patent/DE50206173D1/de not_active Expired - Lifetime
-
2006
- 2006-06-21 CY CY20061100845T patent/CY1105624T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2261786T3 (es) | 2006-11-16 |
| AU2002356739A1 (en) | 2003-06-10 |
| PT1448219E (pt) | 2006-08-31 |
| EP1448219B1 (de) | 2006-03-22 |
| DE10158037A1 (de) | 2003-07-03 |
| DK1448219T3 (da) | 2006-07-31 |
| US20050043214A1 (en) | 2005-02-24 |
| DE50206173D1 (de) | 2006-05-11 |
| EP1448219A1 (de) | 2004-08-25 |
| WO2003045417A1 (de) | 2003-06-05 |
| ATE320817T1 (de) | 2006-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE486840T1 (de) | Modifizierte formen pharmazeutisch aktiver agenzien und verwendungen dafür | |
| CY1105648T1 (el) | Filbanserin για την θεραπεια εξτραπυραμιδικων διαταραχων κινησης | |
| CY1105211T1 (el) | Φαρμακευτικοι συνδυασμοι που πepιλαμβανουν εναν ανταγωνιστη του υποδοχεα p2τ και μελαγατρανη | |
| DE60321929D1 (de) | Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen | |
| CY1107176T1 (el) | Συνθεσεις και μεθοδος για θεραπεια μολυνσης σε βοοειδη και χοιρους | |
| ATE312621T1 (de) | Pharmazeutische formulierungen von thyroidhormonen | |
| DE69808130D1 (de) | Adamantan-derivate | |
| CY1113353T1 (el) | Φαρμακοτεχνικη μορφη αντι-τνf-αλφα αντισωματος | |
| CY1106602T1 (el) | Παραγωγα αδαμαντανιου για τη θεραπεια φλεγμονωδων, ανοσολογικων και καρδιαγγειακων ασθενειων | |
| ATE431738T1 (de) | Opioid-agonist-formulierungen mit freisetzbarem und sequestriertem antagonist | |
| EA200101156A1 (ru) | ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НОВОГО ТИПА НА ОСНОВЕ ОБЛАДАЮЩИХ ХОЛИНЕРГИЧЕСКИМ ДЕЙСТВИЕМ СОЕДИНЕНИЙ И β-МИМЕТИКОВ | |
| HUP0104709A2 (hu) | Eritropoietin vagy eritropoietrinszármazékok alkalmazása agyi iszkémiák kezelésére használható gyógyszer előállítására | |
| AR034213A1 (es) | Composiciones de medicamentos sobre la base de agentes anticolinergicos e inhibidores de pde-iv | |
| CY1106159T1 (el) | Φαρμακευτικη συνθεση που πepιλαμβανει πενιχρα υδατοδιαλυτη σταυροσπορινη, επιφανειοδραστικη ουσια και υδατοδιαλυτο πολυμepες | |
| DE50005529D1 (de) | Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac | |
| ATE426635T1 (de) | Arzneimittelverabreichung | |
| NO20004419L (no) | Ny anvendelse | |
| BR0314797A (pt) | Derivados da pirimidineamida e o uso dos mesmos | |
| DE69815094D1 (de) | 2-(iminoethyl)-aminophenyl - derivate, deren herstellung, deren verwendung als medikamente und diese enthaltende pharmazeutische zubereitungen | |
| UY27929A1 (es) | Composiciones farmaceuticas de farmacos semiordenados y polimeros | |
| ATE209504T1 (de) | Pharmazeutische zusammensetzungen enthaltent ein superoxyddismutase | |
| BRPI0406858A (pt) | Liberação controlada de agentes altamente solúveis | |
| DE60102590D1 (de) | Darreichungsformen zur behandlung von oralen mykosen | |
| CY1105624T1 (el) | Αντιγλαυκωματικο μεσο και χρηση αυτου | |
| HRP20031057B1 (hr) | Tableta koja sadrži cetirizin i pseudoefedrin |